Cellectar Biosciences, Inc. (CLRB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Cellectar Biosciences, Inc. (CLRB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CLRB Cash Flow Statement

Cellectar Biosciences, Inc. (CLRB) cash flow statement — 22-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-6.01M	-4.85M	-4.34M	-4.28M	-5.12M	-9.38M	-10.91M	-9.17M	-14.14M	-13.36M	-9.6M	-8.07M	-7.53M	-7.18M	-7.41M	-7.01M	-5.76M	-5.04M	-4.51M	-6.43M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-17.49%	48.36%	60.19%	53.36%	63.82%	29.77%	-13.73%	-13.62%	-87.8%	-86%	-29.47%	-15.04%	-30.78%	-42.54%	-64.3%	-9.09%	16.27%	-6.04%	-16.6%	-83.58%
Net Income	-6.93M	-5.65M	-5.3M	-4.44M	-5.45M	-6.6M	-2.36M	-14.66M	-919.37K	-26.64M	-7.88M	-17.52M	-10.18M	-7.19M	-7.22M	-7.81M	-7.44M	-6.14M	-5.92M	-5.82M
Depreciation & Amortization	35.52K	-110.02K	49.46K	52.28K	55.56K	56.3K	68.57K	68.57K	66.02K	88.49K	69.96K	41.21K	38.65K	42.56K	38.16K	32.96K	33.9K	43.42K	39.29K	36.79K
Stock-Based Compensation	428.31K	0	0	0	565.39K	562.74K	1.49M	1.53M	0	454.36K	0	497.88K	419.76K	408.21K	361.45K	367.76K	419.95K	303.81K	377.85K	421.16K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	411.31K	371.62K	290.12K	292.92K	-464.97K	340K	-10.05M	1.67M	-11.64M	14.96M	-3.37M	8.17M	1.99M	-1.39M	23.89K	23.01K	25.56K	21.36K	20.56K	19.79K
Working Capital Changes	45.34K	546.78K	611.5K	-176.44K	176.4K	-3.74M	-63.56K	2.22M	-1.65M	-2.22M	1.58M	740.64K	205.06K	946.83K	-620.16K	374.41K	1.2M	731.43K	969.39K	-1.09M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	493.86K	301.28K	408.87K	-664.03K	0	0	0	0	-930.74K	0	1.36M	0	0	0	0	0	0	0	0	0
Cash from Investing	0	-3.38K	-5.88K	0	0	0	-61.29K	0	-21.28K	-21.63K	-266.76K	-597.28K	0	0	-117.86K	-7.07K	-70.98K	-30.07K	-129.74K	-4.06K
Capital Expenditures	0	-3.38K	-5.88K	0	61.29K	0	-61.29K	0	-21.28K	-21.63K	-266.76K	-597.28K	0	0	-117.86K	-7.07K	-70.98K	-30.07K	-129.74K	-4.06K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-61.29K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	31.66M	0	4.99M	5.79M	2.25M	0	0	17.56M	1	43.85M	441K	22.5M	0	3	9.61M	0	0	0	-1	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	31.66M	0	4.99M	5.79M	2.25M	0	0	0	1	0	441K	0	0	0	9.61M	0	0	0	-1	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	17.56M	0	43.85M	0	22.5M	0	3	0	0	0	0	0	0
Net Change in Cash	25.65M	-4.85M	641.74K	1.51M	-2.86M	-9.38M	-10.97M	8.39M	-14.16M	30.47M	-9.42M	13.83M	-7.53M	-7.18M	2.08M	-7.02M	-5.83M	-5.07M	-4.64M	-6.43M
Free Cash Flow	-6.01M	-4.85M	-4.35M	-4.28M	-5.12M	-9.38M	-10.97M	-9.17M	-14.16M	-13.38M	-9.86M	-8.67M	-7.53M	-7.18M	-7.53M	-7.02M	-5.83M	-5.07M	-4.64M	-6.43M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-17.49%	48.32%	60.36%	53.36%	63.88%	29.89%	-11.28%	-5.79%	-88.09%	-86.3%	-30.98%	-23.43%	-29.19%	-41.69%	-62.25%	-9.13%	15.33%	-6.68%	-19.42%	-83.7%
FCF per Share	-0.49	-1.14	-1.03	-1.35	-3.18	-6.11	-7.85	-6.99	-11.35	-13.68	-15.23	-22.99	-20.06	-19.14	-24.27	-34.47	-28.62	-24.89	-22.79	-32.24
FCF Conversion (FCF/Net Income)	0.87x	0.86x	0.82x	0.96x	0.94x	1.42x	4.63x	0.63x	15.38x	0.50x	1.22x	0.46x	0.74x	1.00x	0.60x	0.90x	0.77x	0.82x	0.76x	1.10x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0